Market closed
NLS Pharmaceutics AG/$NLSP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About NLS Pharmaceutics AG
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
Ticker
$NLSP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Zurich, Switzerland
Employees
-
Website
NLSP Metrics
BasicAdvanced
$2.4M
-
-$6.59
-0.52
-
Price and volume
Market cap
$2.4M
Beta
-0.52
52-week high
$1.90
52-week low
$1.30
Average daily volume
75K
Financial strength
Current ratio
0.155
Quick ratio
0.082
Total debt to equity
-18.489
Interest coverage (TTM)
-27.20%
Management effectiveness
Return on assets (TTM)
-227.76%
Return on equity (TTM)
97.31%
Valuation
Price to book
-0.16
Price to tangible book (TTM)
-0.16
Price to free cash flow (TTM)
-0.383
Growth
Earnings per share change (TTM)
-67.19%
3-year earnings per share growth (CAGR)
-38.02%
NLSP News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for NLS Pharmaceutics AG stock?
NLS Pharmaceutics AG (NLSP) has a market cap of $2.4M as of April 16, 2025.
What is the P/E ratio for NLS Pharmaceutics AG stock?
The price to earnings (P/E) ratio for NLS Pharmaceutics AG (NLSP) stock is 0 as of April 16, 2025.
Does NLS Pharmaceutics AG stock pay dividends?
No, NLS Pharmaceutics AG (NLSP) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next NLS Pharmaceutics AG dividend payment date?
NLS Pharmaceutics AG (NLSP) stock does not pay dividends to its shareholders.
What is the beta indicator for NLS Pharmaceutics AG?
NLS Pharmaceutics AG (NLSP) has a beta rating of -0.52. This means that it has an inverse relation to market volatility.